Topic Highlight
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Apr 7, 2009; 15(13): 1554-1580
Published online Apr 7, 2009. doi: 10.3748/wjg.15.1554
Table 1 Populations at increased risk for C. difficile
Patients who take the following drugs
Antibiotics
Proton pump inhibitors
Valacyclovir
Patient characteristics
IBD
Serous underlying illness-comorbidities
Gastrointestinal surgery/manipulations
Advanced age
Immune-compromising conditions (post transplantation)
Peri-partum
Environment
Prolonged stay in health-care settings
Laboratory factors
Hypoalbuminemia
Low levels of anti-toxin and B antibodies